Scholars Central

Editorial Board Member

Kai Kang

Department of Translational Hematology and Oncology Research, USA

About

As published by the journal they serve.

Dr. Kang got comprehensive pharmaceutical training in the pharmaceutical universities in China. He Received his Ph.D. degree in the Chinese University of Hong Kong. Now he is a post-doctoral research fellow in the Department of Immunology, Lerner Research Institute, Cleveland Clinic. He has long experience in translational study in tumor field. His current main interest is to study the immune priming effects of low dose hypomethylation agents against cancer in vitro and in vivo.

Research interests

  • Drug research and development
  • Translational study against human disease
  • Tumor immunotherapy

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.